And you thought Nvidia’s move higher was impressive at 7%? Salesforce shares are surging by 18% after the company reported better-than-expected fiscal second-quarter results, raised its full-year outlook and highlighted accelerating demand for its AI products.
- Revenue: $11.35 billion, up 11% year over year and slightly above expectations near $11.3 billion.
- Adjusted EPS: $5.90 versus $3.27 expected. However, the result included a $2.53-per-share investment gain, largely tied to Salesforce’s stake in Anthropic. Excluding that benefit, adjusted EPS was approximately $3.37.
- Current remaining performance obligations: $33.5 billion, up 14% year over year and ahead of expectations—a positive indication of future contracted revenue.
- Agentforce and Data 360 ARR: Nearly $3.9 billion, rising more than 210% from a year ago.
- Third-quarter revenue guidance: $11.42 billion to $11.50 billion.
- Full-year revenue guidance: Raised to $46.1 billion–$46.4 billion from $45.9 billion–$46.2 billion.
- Full-year adjusted EPS: Raised to $16.67–$16.71 from $14.06–$14.12.
Salesforce also expanded its partnership with Anthropic through a new initiative called “Claudeforce,” which will integrate Claude’s AI models with Salesforce’s customer data and business applications. Overall, the report helped ease concerns that generative AI could undermine traditional software companies. Instead, Salesforce showed signs that Agentforce, Data 360 and its broader AI strategy are beginning to accelerate growth, providing the fundamental catalyst for today’s sharp move higher.
Wall Street responded favorably to Salesforce’s better-than-expected quarter and improving AI narrative, with analysts broadly raising their price targets. Jefferies and BTIG moved their objectives to $300, Raymond James increased its target to $310, while Evercore ISI raised its target to $290. Even more cautious firms adjusted substantially higher, with Morgan Stanley lifting its target to $235 from $185 (the price is above their target now) while maintaining an Equal Weight rating. The revisions reflect stronger cRPO growth, improved margins, higher guidance and greater confidence that Agentforce and the company’s expanded Anthropic partnership can support future growth. However, several neutral-rated targets remain near or below the stock’s post-earnings price, suggesting the sharp rally has already captured some of the improved outlook.
So what are the charts telling traders?
In the video above I outline the technical levels in play for salesforce after the short run to the upside. What are the risks, what are the targets now given the move. Where should traders feel uncomfortable should there be a rotation back to the downside.
This article was written by Greg Michalowski at investinglive.com.